Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

伊尼妥单抗联合吡咯替尼治疗HER2阳性晚期乳腺癌1例

GUI Xiu?juan,ZHAO Jian?li, WANG Ying,CHAI Jie,DIN Lin?xiao?xiao,YAO He?rui

Lingnan Modern Clinics in Surgery（2021）

Cited 0|Views2
No score
Abstract
HER2阳性乳腺癌约占所有乳腺癌的15％～20％,其侵袭性强且预后较差.曲妥珠单抗的应用显著改善了患者的预后,但仍有部分患者会出现曲妥珠单抗耐药.本文报道一例应用"伊尼妥单抗"联合"吡咯替尼"及"艾立布林"后疗效显著的曲妥珠单抗原发耐药的晚期乳腺癌患者.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined